BioSpace News Archive

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced the presentation of preclinical data that provide further support of its clinical stage FPI-2059, a neurotensin receptor 1 (NTSR1) targeted alpha therapy (TAT), and additional preclinical development programs.

Nevro Corp. announced that Kevin Thornal has been appointed Chief Executive Officer and President of Nevro, effective April 24, 2023, and will also be appointed to the Board of Directors.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”) is pleased to announce that world renowned inflammasome researchers and inventors of ZyVersa’s Inflammasome ASC Inhibitor IC 100 from the University of Miami Miller School of Medicine have published a scientific paper in the peer-reviewed journal, Biomaterials.

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators presented positive preclinical data for the NPRL2 gene (also known as the TUSC4 gene).

Bicara Therapeutics today announced the publication of a manuscript in Cancer Research, a journal of the American Association for Cancer Research (AACR), describing the design and characterization of its lead program, BCA101, a first in class dual-action bifunctional antibody designed to inhibit EGFR and disable TGF-β directly at the tumor site.

Biotricity Inc., a leading medical diagnostic and consumer healthcare technology company, reported that it reached a record $12 million annualized revenue run rate in March 2023.

Element Biosciences, Inc. has signed distribution agreements with companies based in Israel, South Korea, Australia, and the United Arab Emirates to bring its AVITI System to more customers around the world.

Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.

The ongoing exhibition ‘Of Genes and Human Beings’ at the national German DHMD museum in Dresden, highlights multiple technological advances in the genetic field over the last century and especially the last 20 years.

Medical device company Baymatob has successfully completed one of Australia’s largest maternity health studies for a medical device, enrolling 500 mothers in a pilot study to evaluate its AI-guided labor monitoring device, Oli.